Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

2.2K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.2K
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

1.1K
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
1.1K
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

809
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
809
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

708
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
708
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

642
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
642
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

712
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
712

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Renal Dose Adjustment in European Primary Care: Clinical Nuances and Practical Challenges.

Journal of clinical medicine·2026
Same author

Statistical Recommendations for Immunity, Inflammation and Disease.

Immunity, inflammation and disease·2026
Same author

Amanita muscaria in the evolving novel psychoactive substances landscape - toxicological risks and clinical implications: a narrative review.

Frontiers in pharmacology·2026
Same author

Estimating work-related indirect costs in allergic rhinitis and asthma using a daily combined symptom-medication score: a MASK-air® study in collaboration with the EAACI Methodology Committee.

The journal of allergy and clinical immunology. In practice·2026
Same author

Hidden potential, visible impact: mentorship through the American Society for Clinical Pathology Mentorship Program in advancing research in low- and middle-income countries.

Laboratory medicine·2026
Same author

Ensuring valid and transparent statistical practices in infectious disease research: A practical review.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same journal

Decoding the serotonin-alcohol crosstalk: the role of central serotonergic dysregulation in alcohol use disorder.

Pharmacological reports : PR·2026
Same journal

Investigating the interaction between aryl hydrocarbon receptor and methotrexate: implications for treatment resistance in rheumatoid arthritis patients.

Pharmacological reports : PR·2026
Same journal

Hypocholesterolemic agents and the gut microbiota: a review of interactions and modulatory activity.

Pharmacological reports : PR·2026
Same journal

Italian regional data and oropharyngeal adverse events to drugs and vaccines: insights from a 3-year spontaneous reporting (2022-2024).

Pharmacological reports : PR·2026
Same journal

AMPA receptor modulation in depression: from molecular mechanisms of plasticity to therapeutic translation.

Pharmacological reports : PR·2026
Same journal

A discovery-based proteomic approach of epidermal growth factor and growth hormone-releasing peptide-6 in a model of acute ischemic stroke.

Pharmacological reports : PR·2026
See all related articles

Related Experiment Video

Updated: Feb 27, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

4.7K

Magnesium in schizophrenia.

Michal Ordak1, Joanna Matras1, Elzbieta Muszynska2

  • 1Department of Pharmacodynamics, Faculty of Pharmacy, Medical University of Warsaw, Centre for Preclinical Research and Technology (CePT), Warszawa, Poland.

Pharmacological Reports : PR
|June 27, 2017
PubMed
Summary
This summary is machine-generated.

Schizophrenia may involve magnesium disturbances, but studies conflict. Measuring ionized magnesium, crucial for brain function, is key to understanding its role and potential therapeutic benefits in schizophrenia treatment.

Keywords:
MagnesiumSchizophrenia

More Related Videos

Author Spotlight: Unraveling Seizure Dynamics and Novel Therapeutics for Status Epilepticus Using CMOS High-Density Microelectrode Array Systems
06:28

Author Spotlight: Unraveling Seizure Dynamics and Novel Therapeutics for Status Epilepticus Using CMOS High-Density Microelectrode Array Systems

Published on: September 27, 2024

3.3K
Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

19.4K

Related Experiment Videos

Last Updated: Feb 27, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

4.7K
Author Spotlight: Unraveling Seizure Dynamics and Novel Therapeutics for Status Epilepticus Using CMOS High-Density Microelectrode Array Systems
06:28

Author Spotlight: Unraveling Seizure Dynamics and Novel Therapeutics for Status Epilepticus Using CMOS High-Density Microelectrode Array Systems

Published on: September 27, 2024

3.3K
Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

19.4K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Biochemistry

Background:

  • Psychopathological symptoms, including schizophrenia, are linked to magnesium metabolism issues.
  • Existing research on magnesium levels in schizophrenia patients shows contradictory findings.
  • Extracellular magnesium measurement may explain discrepancies, as magnesium is primarily intracellular.

Purpose of the Study:

  • To highlight the lack of data on ionized magnesium in schizophrenia.
  • To explore the potential of magnesium supplementation in schizophrenia pharmacotherapy.
  • To investigate the role of magnesium ions in NMDA and GABA receptor function.

Main Methods:

  • Review of existing literature on magnesium levels and schizophrenia.
  • Discussion of the importance of intracellular and ionized magnesium fractions.
  • Exploration of magnesium's mechanisms of action on neurotransmitter receptors.

Main Results:

  • Ionized magnesium, representing a significant portion of total magnesium, has not been studied in schizophrenia.
  • Magnesium's influence on NMDA and GABA receptors requires further investigation.
  • Preliminary studies suggest magnesium supplementation may enhance schizophrenia pharmacotherapy effectiveness.

Conclusions:

  • Further research is essential to elucidate the role of ionized magnesium in schizophrenia.
  • Magnesium supplementation shows promise for improving therapeutic outcomes in psychiatric disorders.
  • Understanding magnesium's multidirectional activity could unlock significant therapeutic potential in psychiatry.